Dyne Therapeutics, Inc. (NASDAQ:DYN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jason Rhodes Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Replimune Group, Inc. (Director · Jul 19, 2018 – Apr 1, 2022 · Past); Epizyme Inc (President, CFO and Treasurer · May 30, 2013 – Sep 22, 2014 · Past) | Chairman · Since at least Sep 16, 2020 |
| John Cox Other companies: Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Bioverativ Inc (Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past); Repligen Corporation (Director · Nov 15, 2013 – Mar 24, 2020 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past) | President and Chief Executive Officer · Since at least Mar 25, 2024 |
| Joshua Brumm Other companies: Crescent Biopharma, Inc. (Chief Executive Officer · Since at least Jun 13, 2025); Kaleido Biosciences, Inc. (See Remarks · Feb 27, 2019 – Mar 4, 2019 · Past); Aravive Inc (COO and CFO · Nov 12, 2015 – Oct 19, 2017 · Past) | CEO & President, Director · Sep 16, 2020 – Mar 8, 2024 · Past |
| Erick J. Lucera Other companies: SAB Biotherapeutics, Inc. (Director · Since at least Dec 16, 2025); Beyond Air, Inc. (Director · Since at least Nov 4, 2025) | Chief Financial Officer · Since at least Mar 31, 2025 |
| Lucia Celona Other companies: Apellis Pharmaceuticals, Inc. (See Remarks · Aug 5, 2019 – Feb 10, 2020 · Past); Bioverativ Inc (EVP, HR & Corp Commun. Officer · Dec 22, 2016 – Mar 8, 2018 · Past) | Chief Human Resources Officer · Since at least Nov 5, 2026 |
| Richard William Scalzo Other companies: Crescent Biopharma, Inc. (Chief Financial Officer · Since at least Jun 13, 2025); Kaleido Biosciences, Inc. (Principal Accounting Officer · Oct 11, 2019 – Oct 11, 2019 · Past) | SVP, Head of Finance & Admin. · Sep 16, 2020 – Mar 11, 2025 · Past |
| Brian S. Posner Other companies: Arch Capital Group Ltd. (Director · Since at least May 5, 2026) | Board Member · Since at least Oct 2, 2025 |
| David Lubner Other companies: Crescent Biopharma, Inc. (Director · Since at least Jul 31, 2025) | Board Member · Since at least Apr 28, 2026 |
| Douglas Kerr Other companies: Generation Bio Co (CHIEF MEDICAL OFFICER · Jun 11, 2020 – Jan 29, 2024 · Past) | Head of R&D and CMO · Since at least Sep 3, 2024 |
| Vikram Karnani Other companies: Collegium Pharmaceutical, Inc. (PRESIDENT & CHIEF EXECUTIVE OFFICER · Since at least Nov 7, 2024) | Board Member · Since at least Dec 22, 2025 |
| Alessandro Martuscelli | Chief Legal Officer · Since at least Nov 5, 2026 |
| Axel Wiest | Senior Vice President, Head of Portfolio Strategy & Operations · Since at least Nov 5, 2026 |
| Barry Greene | Board Member · Since at least Jun 22, 2026 |
| Carlo Incerti | Board Member · Since at least Nov 5, 2026 |
| Catherine Stehman-Breen | Board Member · Since at least Nov 5, 2026 |
| Debra Feldman | Chief Regulatory Affairs Officer · Since at least Nov 5, 2026 |
| Dirk Kersten | Board Member · Since at least Apr 15, 2026 |
| Doug Kerr | Head of Research & Development and Chief Medical Officer · Since at least Sep 29, 2026 |
| Ed Hurwitz | Board Member · Since at least Nov 4, 2026 |
| James P. Bilotta | Chief Digital Information Officer · Since at least Nov 5, 2026 |
| Johanna Friedl-Naderer | Chief Commercial Officer · Since at least Jun 5, 2025 |
| José Juves | Chief Corporate & Patient Affairs Officer · Since at least Nov 5, 2026 |
| Monica Fay | Chief Medical Affairs Officer · Since at least Nov 5, 2026 |
| Oxana Beskrovnaya | Chief Innovation Officer · Since at least Sep 16, 2020 |
| Raj Manchanda | Chief Technical Officer · Since at least Nov 5, 2026 |
| Ranjan Batra | Chief Scientific Officer · Since at least Sep 3, 2026 |
| Romesh Subramanian | Chief Scientific Officer · Sep 16, 2020 – Sep 16, 2020 · Past |
| Vikram Ranade | Chief Business Officer · Since at least May 8, 2025 |